Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents

Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents

Despite the BNT162b2 vaccination coverage, rapid transmission of Omicron SARS-CoV-2 has occurred, which is suspected to be due to the immune escape of the variant or waning vaccine efficacy of multiple BNT162b2 vaccination doses. Our study aims to compare immunogenicity against Omicron prior to and...

Full description

Bibliographic Details
Main Authors: Pavinee Assavavongwaikit, Napaporn Chantasrisawad, Orawan Himananto, Chayapa Phasomsap, Pintusorn Klawaja, Sapphire Cartledge, Rachaneekorn Nadsasarn, Thidarat Jupimai, Surinda Kawichai, Suvaporn Anugulruengkitt, Thanyawee Puthanakit, on behalf of the Study Team
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
SARS-CoV-2 vaccine
booster dose
neutralizing antibody titer
anti-SARS-CoV-2 IgG
BNT162b2 vaccine
SARS-CoV-2 Omicron variant
Online Access:https://www.mdpi.com/2076-393X/10/7/1098

Internet

https://www.mdpi.com/2076-393X/10/7/1098

Similar Items